The latest precision medicine news

The Dangerous Bet Behind Big Pharma’s Silence

Why dismantling America’s biomedical innovation engine is a long-term threat to the very industry staying quiet about it. A recent piece by Steven Usdain, which was also highlighted by Holden Thorp, got me thinking: are...read more

DNA Origami used to build novel vaccines

Image credit: Bannard and Howarth. (2026) Despite the current public image challenges surrounding vaccines, progress in basic science and application continues to advance rapidly. A particularly significant...read more

When “Anonymous” Isn’t: The UK Biobank Data Exposure and the Limits of Health Data Privacy

The UK Biobank data exposure highlights a growing risk in modern health research: sensitive data is not only vulnerable to breaches, but to systemic leakage through normal scientific practices. This raises urgent...read more

From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences

From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences I’ve been spending some time thinking on how Voice of the Customer (VoC) programs are evolving as artificial intelligence (AI) becomes...read more

From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand

TL;DR 2025 shifted healthcare from experimentation to execution AI moved from tools to infrastructure 2026 will reward disciplined execution over vision Why this matters for precision medicine + generative AI This...read more

Tempus Scoops Up OneOme’s Pharmacogenetics Assets as Precision Medicine Shakeout Continues

Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more

Abbott to acquire Exact Sciences

• Acquisition adds a new growth vertical to Abbott’s already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segments•...read more

Inside the Biology of 116 Years of Life: What Multiomics Reveals About Extreme Longevity

At enlightenbio, we are deeply committed to studying longevity and health span, which aligns with our personal and professional interests in biological science. For more on this, please see a couple of earlier...read more

Invert launches Invert Assist, an AI-powered analysis interface built for bioprocess

ISAN FRANCISCO, CA, October 28, 2025 – Invert, a pioneer in AI-driven bioprocess software solutions, today announced the launch of Invert Assist, an AI-powered analysis interface for bioprocess that enables users to...read more

New Therapy Potential of Targeted Protein Degradation

New approaches in drug discovery currently focus on the concept of a „magic bullet“ molecule. One that precisely targets an intended pharmacological role without off-target actions or unwanted side-effects. Traditional...read more

Stop Guessing. Start Diagnosing: The Marketing & Product-Market Fit Scorecard

I recently conducted a LinkedIn survey to understand why most startups fail. I asked “Most startups don’t fail because of a bad idea — they fail because founders ignore the warning signs. I’m curious — which of these do...read more

BEVIMI Launches: A New Bid to Bring Pharma-Grade Rigor to Brain Health

This past week, BEVIMI was officially announced. This new company aims to bring pharmaceutical-style rigor to the consumer brain-health market. Headquartered in Greenwich, Connecticut and led by co-founders Paul...read more

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines New offering expands Lilly Catalyze360’s support for early-stage drug development INDIANAPOLIS, Sept...read more

Why Are We Still Talking About Data Infrastructure for Life Sciences in 2025?

“In my twenty-five years in the Life Sciences industry, I’ve observed countless organizations adopt, revise, dismantle, and rebuild their data infrastructure.” While the rapid advancements of data technology certainly...read more

Tempus Announces the Acquisition of Paige

Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated Tempus AI, Inc. (NASDAQ: TEM), a technology company leading...read more

Strong Grip, Strong Future: A Key Predictor of Healthy Aging

And why your handshake may reveal more about your health than your blood pressure Indicators of Long-Term Health and Longevity In this next longevity blog, I’m excited to delve into phenotypic biomarkers of healthy...read more

Why Most Startups Fail: The Brutal Truth and How to Beat the Odds

Launching a startup is exhilarating—a whirlwind of big ideas, bold moves, sleepless nights, and passionate pitches. But behind the scenes, the harsh reality remains: Most startups fail. Depending on which study you...read more

10x Genomics to Acquire Scale Biosciences

Acquisition Will Further Expand Chromium’s Capabilities PLEASANTON, Calif., Aug. 7, 2025 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology...read more

The Critical Link Between CROs and Sponsors: Making Data Work for You

Maximizing Focus, Minimizing Cost: The Strategic Logic of CRO Engagement Outsourcing to Contract Research Organizations (CROs) has been a fundamental practice in therapeutic and device discovery and early development...read more

SCIMap: View Impact of Federal Health Research Cuts

Current Economic Loss: $9.8B and 42K jobs Future Economic Loss: $16B and 68K jobs per year Report TItle: White House FY 2026 NIH Budget Cuts Will Cause Widespread Economic LossRelease Date: June 23, 2025Science and...read more

It’s Not the Quantity but the Quality of Data That Enables AI/ML-Based Bioprocess Applications

Over the past 30 years, product titers have increased by almost 20% year over year (Langer and Rader, 2015). Since the 1990s, this has translated into dramatic increases in production, from an average of <1g/L to...read more

Most Life Science Startups Hire Too Small. Here’s Why That’s a Costly Mistake

When early-stage biotech and digital health founders need to get to market, their instinct is to hire a junior marketer. It feels like the right first step: someone to manage social media, build a slide deck, maybe...read more

Neither AI nor ChatGPT Will Save Your Drug Discovery Pipeline …

AI is having a tough time generalizing molecule structures when your data is more scarce than the complexity of your problem allows for “Boring is good” is the mantra of successful engineering. This is in contrast to...read more

Rewiring Precision Medicine: How AI Is Transforming Science and Business

Artificial intelligence is transforming every link in the precision medicine value chain. From drug discovery and manufacturing to supply chain optimization and laboratory operation, AI’s impact is both deep and...read more

Ultima Genomics Selected to Support the World’s Largest Proteomics Studies to Date Led by Regeneron Genetics Center

FREMONT, Calif., June 26, 2025 /PRNewswire/ — Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that its...read more

Germany Calls for a Policy Shift to Address their Country’s Aging Population

As I highlighted in my previous blog, A Look at Human Longevity & Life Expectancy, our global population is experiencing a significant and rapid increase in its aging demographic. For instance, Germany is projected...read more

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company’s multiomics strategy

Combines highly complementary proteomics expertise with Illumina’s industry-leading product innovation and global market reach Positions Illumina to achieve growth in a large, expanding market Illumina and...read more

23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process

TTAM Commits to Comply with Company’s Privacy Policy and All Applicable Laws TTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards to Enhance Protections for Customer Data and Privacy No...read more

Dozens of states sue to block the sale of 23andMe personal genetic data without customer consent

PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit...read more

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

New AI algorithm accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome at scale for the first time SAN DIEGO, May 29, 2025 /PRNewswire/ — Illumina Inc...read more

Our Top Selection of Precision Medicine News

Precision medicine, omics, and genetics news from around the world.